Skip to Content
Merck
  • EDTA-dependent pseudothrombocytopenia confirmed by supplementation of kanamycin; a case report.

EDTA-dependent pseudothrombocytopenia confirmed by supplementation of kanamycin; a case report.

The Korean journal of internal medicine (2002-05-17)
Hae Lyun Ahn, Young Il Jo, Young Suk Choi, Jung Yeon Lee, Hae Woon Lee, Seong Ryul Kim, Joon Sim, Weon Lee, Chun Jo Jin
ABSTRACT

EDTA-dependent pseudothrombocytopenia (PTCP) is the phenomenon of a spurious low platelet count due to EDTA-induced aggregation of platelets. Since the failure to recognize EDTA-dependent PTCP may result in incorrect diagnosis and inappropriate treatment, the recognition of this phenomenon is very important. We report an insidious case of EDTA-dependent PTCP confirmed by supplementation of kanamycin to anticoagulant in a 53-year-old women. Although sodium citrate and heparin usually prevented the aggregation of platelets in EDTA-dependent PTCP patients, these anticoagulants failed in preventing PTCP in our case. EDTA-dependent PTCP was confirmed by the findings that the clumping of platelets on microscopic evaluation was found in EDTA-anticoagulated blood samples, whereas thrombocytopenia and platelet aggregation were not revealed in the sample supplemented with kanamycin.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
0.5M EDTA